Archive - February 2018
FDA Approves Erleada (apalutamide) for Non-Metastatic Castration-Resistant Prostate Cancer
Highly Processed Foods Tied to Higher Cancer Risk
Being a Single Dad Can Take a Big Toll on Health
New Treatment Apalutamide (Erleada) Approved for Prostate Cancer That Resists Hormone Therapy
First Blood Test to Evaluate Potential Concussions Approved
New Treatment Approved for Prostate Cancer That Resists Hormone Therapy
Community Health Systems selling Louisiana hospital
Smartphone ECG device KardiaMobile rolled out to NHS to combat atrial fibrillation